What drug class is Ilaris?
What drug class is Ilaris?
Canakinumab
| Monoclonal antibody | |
|---|---|
| Trade names | Ilaris |
| Other names | ACZ885, ACZ-885 |
| AHFS/Drugs.com | Monograph |
| License data | EU EMA: by INN US DailyMed: Canakinumab US FDA: Canakinumab |
What is Ilaris used for?
ILARIS is indicated for the treatment of active Still’s disease, including Adult-Onset Still’s Disease (AOSD) and Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 years and older.
What is Ilaris injection?
What is Ilaris? Ilaris (canakinumab) is a monoclonal antibody that blocks certain proteins in the body that can affect inflammation and other immune responses. Canakinumab is used to treat certain types of periodic fever syndromes, sometimes called auto-inflammatory syndromes.
What is J0638?
J0638 is a valid 2021 HCPCS code for Injection, canakinumab, 1 mg or just “Canakinumab injection” for short, used in Medical care.
Is ILARIS a biologic?
One biologic is ILARIS®, the once-monthly injectable biologic medicine that’s FDA approved for active Still’s disease, including SJIA in children 2 years of age and older. ILARIS treats symptoms that happen around the joints and those that occur throughout the body.
Where do you inject ILARIS?
Ilaris is intended for subcutaneous use. This means that it is injected through a short needle into the fatty tissue just under the skin. If you have gouty arthritis, your treatment will be overseen by a doctor with specialist training. Ilaris should be injected by a healthcare professional only.
How is ILARIS administered?
ILARIS is administered every eight weeks as a single dose via subcutaneous injection. Using aseptic technique, reconstitute each vial of ILARIS by slowly injecting 1 mL of preservative-free Sterile Water for Injection with a 1 mL syringe and an 18 G x 2” needle.
Is ILARIS self injectable?
A once-monthly injection ILARIS® is not given as an intravenous infusion (infused inside a vein over time); it is given as a subcutaneous injection (right under the skin) every 4 weeks by a doctor or nurse.
Is ILARIS self administered?
Ilaris should be injected by a healthcare professional only. If you have CAPS, TRAPS, HIDS/MKD, FMF or Still’s disease (AOSD or SJIA), you may inject yourself with Ilaris after proper training, or a caregiver may inject it for you. Ilaris is injected every 8 weeks as a single dose.
What are the indications of Ilaris?
Ilaris 1 INDICATIONS AND USAGE. Ilaris is indicated for the treatment of Tumor Necrosis Factor (TNF)… 2 DOSAGE AND ADMINISTRATION. INJECTION FOR SUBCUTANEOUS USE ONLY. 3 DOSAGE FORMS AND STRENGTHS. For injection: 150 mg lyophilized powder in single-dose vials… 4 CONTRAINDICATIONS. Confirmed hypersensitivity to the active substance or to any…
What is Ilaris ® (Canakinumab)?
Please see full Prescribing Information, including Medication Guide. ILARIS ® (canakinumab) is a prescription medicine injected by your healthcare provider just below the skin (subcutaneous) used to treat: Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients
What is the recommended dose of ILARIS for systemic juvenile idiopathic arthritis?
Systemic Juvenile Idiopathic Arthritis (SJIA) The recommended dose of Ilaris for SJIA patients with a body weight greater than or equal to 7.5 kg is 4 mg/kg (with a maximum of 300 mg) administered every 4 weeks.
Is ILARIS safe and effective for children?
It is not known if ILARIS is safe and effective when used to treat SJIA in children under 2 years of age or when used to treat CAPS in children under 4 years of age. ILARIS is a registered trademark of Novartis AG. Novartis is closely monitoring the COVID-19 (coronavirus) situation and is committed to the safety of patients.
